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Abstract 
 
Background 
Both active smoking and secondhand smoke (SHS) are important risk factors for many age-
related diseases.  Active smoking is associated with shortened telomere length. However, 
whether SHS accelerates telomere attrition with age is uncertain. The aim of this study was to 
examine the association between SHS exposure and shortening by age of leukocyte telomere 
length among adult non-smokers. 
Methods 
We undertook a cross-sectional study of the association between self-reported levels of SHS 
exposure and telomere length shortening per annum on a subgroup of participants from the 
Scottish Family Health Study. Inclusion was restricted to non-smokers aged ≥ 18 years who 
had provided self-reported overall usual SHS exposure (total hours per week) and blood 
samples for telomere analysis. Linear regression models were used to compare T/S ratio by age 
according to SHS exposure.  
Results 
Of the 1,303 eligible participants, 779 (59.8%) reported no SHS exposure, 495 (38.0%) low 
exposure (1-19 hours per week) and 29 (2.2%) high exposure (≥20 hours per week). In the 
univariate linear regression analyses, relative telomere T/S ratio declined with increasing age 
in all exposure groups. Telomere length decreased more rapidly with increasing age among 
those with high exposure to SHS (adjusted coefficient -0.019, 95% CI -0.031- -0.007) when 
compared with both those with no exposure to SHS (adjusted coefficient -0.006, 95% CI -
0.008- -0.004) (high vs no SHS: p=0.010) and those with low exposure to SHS (adjusted 
coefficient -0.005, 95% CI -0.007- -0.003) (high vs low SHS: p=0.005).  
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Conclusion 
Our findings suggest that high SHS exposure may accelerate normal biological ageing and 
support efforts to protect the public from SHS exposure. Further studies on relevant 
mechanisms should be conducted.  
 
MeSH terms 
telomere length, secondhand smoke, biological ageing 
 
Key messages 
 Telomere length decreased more rapidly with increasing age among those with high 
exposure to SHS when compared with both those with no exposure to SHS and those 
with low exposure to SHS.  
 Our findings suggest that high SHS exposure may accelerate normal biological ageing. 
 Our study supports the efforts to protect the public from SHS exposure. 
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Introduction 
 
Telomeres are nucleoprotein complexes at the end of the chromosomes, which protect the 
chromosomal DNA from deterioration and end-to-end fusion. 1 Telomeric DNA comprises 
stretches of repetitive (TTAGGG)n sequence which is eroded with each cycle of cell division 
as part of the end replication problem. 2 Telomere attrition normally limits cells to a fixed 
number of divisions and eventually results in the loss of genetic information from the cell’s 
chromosomes with further divisions. 1, 3 Environmental factors, including cigarette smoking, 
that elevate levels of oxidative stress can accelerate the attrition and therefore biological ageing. 
4-6 Previous studies have demonstrated that shorter telomere length is associated with common 
age-related diseases, including cardiovascular disease and chronic obstructive pulmonary 
disease, and a shorter life span, through mechanisms involving oxidative stress associated with 
cigarette smoking. 7-9 Several studies have suggested that individuals with shorter telomere 
length have increased risk of developing certain types of cancer. 10, 11  
 
Both active cigarette smoking and secondhand smoke (SHS) are important risk factors for many 
age-related diseases, 12, 13 cancer, 14, 15 and mortality, 16, 17 and are associated with increased 
oxidative stress, chronic inflammation and endothelial dysfunction 18. Previous studies on 
active smoking have demonstrated a dose-response relationship between cumulative lifetime 
exposure to cigarette smoking and telomere length attrition. 8-10, 19 Studies also now suggest that 
prenatal tobacco exposure is associated with shortened telomere length in children 20 and 
newborn babies 21.  
 
SHS is a mixture of side-stream smoke from the burning cigarette tip and mainstream smoke 
exhaled by the smoker. It contains at least 250 harmful chemicals including carcinogens, carbon 
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monoxide and tar (www.who.int/mediacentre/factsheets/fs339/en/). Side-stream smoke, in 
particular, contains higher concentrations of toxic gases and small (<2.5 µm), respirable 
particles than mainstream smoke. 22-25 
 
To our knowledge, very few studies have examined the association between SHS exposure in 
adulthood and leukocyte telomere length attrition. 26, 27 In one study, the primary aim was to 
examine the relationship between levels of traffic pollution and telomere length. The 
investigators reported shorter telomere length in traffic officers than indoor office workers. The 
study was underpowered for the secondary aim of studying the relationship between telomere 
length and SHS exposure among the sub-group of never smokers and it found no significant 
association. 26 To examine the association between levels of SHS exposure and telomere 
attrition per year of age among adult non-smokers, we conducted a cross-sectional study using 
a subgroup of individuals from the Scottish Family Health Study who had already had telomere 
assays performed as part of a previous study of biological aging. 
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Methods 
 
Data sources 
Generation Scotland: the Scottish Family Health Study (GS:GFHS) is a family-based, cross-
sectional study of the general population, with a specific focus on cardiovascular risk factors 
and disease (http://www.generationscotland.org). Probands aged between 35 and 55 years were 
randomly selected for invitation from the records of general practitioners based in Glasgow and 
Dundee, Scotland. Between 2006 and 2011, 7,953 probands were recruited along with 16,007 
consenting first degree relatives aged ≥18 years; producing a total of 23,960 participants. 28 All 
participants completed a questionnaire that provided information on demographics (including 
age, sex and postcode of residence) and lifestyle (including smoking status, and number of 
hours of exposure per week to SHS). Trained staff measured height and weight and collected 
blood samples from consenting participants. 
 
Ethical approval for the GS:SFHS was obtained from NHS Tayside Committee on Medical 
Research Ethics (REC Reference Number: 05/S1401/89). GS:SFHS has been granted Research 
Tissue Bank status by the Tayside Committee on Medical Research Ethics (REC Reference 
Number: 10/S1402/20) providing generic ethical approval for a wide range of uses within 
medical research. Permission to use the GS:SFHS data and access to the blood samples was 
provided following review by the GS:SFHS Access Committee.  
 
This study used existing data on a sub-group of 1,779 SFHS participants, randomly selected to 
participate in a study on ageing. DNA was extracted from peripheral blood leukocytes using 
Maxwell automated purified system (Promega, WI, USA). Telomere length in the DNA 
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samples were determined by quantitative-polymerase chain reaction (Q-PCR) blindly using a 
Roche Light Cycler LC480 (Roche Diagnostics, Indianapolis, Indiana, USA). 29   
 
Analyses were performed in triplicate for each sample using a single-copy gene amplicon 
primer set (acidic ribosomal phosphoprotein, 36B4) and a telomere-specific amplicon primer 
set. 30 A cut-off 0.15 for the standard deviation (SD) of the threshold cycle (Ct) for sample 
replicates was used as a quality control parameter for the amplification. The samples were 
reanalysed if a SD above 0.15 was encountered. The average SD across plates was 0.07. 
Relative telomere length was estimated from Ct scores using the comparative Ct method when 
telomere and control gene assays yielded similar amplification efficiencies. The ratio of 
telomere repeat copy number to single copy gene number (T/S) ratio in experimental samples 
relative to a control sample DNA was determined. This normalised T/S ratio was defined as the 
estimate of relative telomere length (relative T/S). The inter-assay variation was tested by 
comparing the relative T/S estimates for positive controls on every assay plate. The average 
inter-assay coefficient of variance was 0.58% for telomere length and 0.23% for 36B4. 29, 31, 32 
 
Inclusion criteria and definitions 
Inclusion was restricted to self-reported non-smokers (never or ex-smokers) aged ≥18 years 
who had provided blood samples for telomere analysis. Area-based socioeconomic status was 
measured using the Scottish Index of Multiple Deprivation (SIMD) 
(www.scotland.gov.uk/topics/Statistics/SIMD). There are 6,505 datazones based on the 
postcode of residence, with a mean population of 800. The SIMD for each datazone is derived 
from information on income, employment, health, education, housing, crime and access to 
services and is grouped into deprivation quintiles for the Scottish general population, ranging 
from 1 (most deprived) to 5 (least deprived). Body mass index (BMI) was defined as: normal 
weight (<25 kg/m2), overweight (25-30 kg/m2) and obese (≥30 kg/m2). Levels of usual, overall 
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SHS exposure were self-reported and categorised into: no exposure, low exposure (1-19 hours 
per week) and high exposure (≥20 hours per week). 
 
Statistical analyses 
The characteristics of this study population were summarised using frequencies and percentages. 
The differences between the exposure groups were assessed using chi-square tests. Linear 
regression models were used to compare the coefficients (slopes) in telomere T/S ratio by age 
between different exposure groups. Statistical significance was defined as p<0.05 in two-sided 
tests. All statistical analyses were undertaken using Stata 12.0 (Stata Corporation, College 
Station, Texas, USA). 
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Results 
 
Of the 1,779 SFHS participants, 1,721 had provided adequate blood samples for telomere assays. 
Among these, 1,433 were self-reported non-smokers. Of the non-smokers, 1,303 provided self-
reported SHS exposure status and therefore comprised this study population. Among these, 861 
(66.1%) were men and 442 (33.9%) women, 846 (64.9%) classified themselves as never 
smokers and 457 (35.1%) as ex-smokers; of the latter, 404 (88.4%) had quit smoking for at 
least one year. Among the 1,303 eligible participants, 779 (59.8%) reported no SHS exposure, 
495 (38.0%) low exposure (1-19 hours per week), 29 (2.2%) high exposure (≥20 hours per 
week) (Table 1). Participants with high SHS exposure were older in age (p for trend=0.025), 
lived in more socioeconomically deprived areas (p for trend<0.001), and were more likely to 
be obese (p for trend=0.012) when compared with participants with no SHS exposure. 
 
In the univariate linear regression analyses, relative telomere T/S ratio declined with increasing 
year of age in all exposure groups. Telomere length decreased more rapidly with increasing age 
among those with high exposure to SHS (unadjusted coefficient -0.015, 95% CI-0.025- -0.005, 
p<0.001) when compared with both those with no exposure to SHS (unadjusted coefficient-
0.006, 95% CI-0.007- -0.004, p<0.001) (high vs no SHS: p=0.047) and those with low exposure 
to SHS (unadjusted coefficient -0.006, 95% CI -0.008- -0.004, p<0.001) (high vs low SHS: 
p=0.047). After adjustment for sex and deprivation quintiles, the differences were more 
statistically significant: reduction per year of age among those exposure to high levels of SHS 
(adjusted coefficient -0.019, 95% CI -0.031- -0.007, p=0.003) compare with those with no 
exposure (adjusted coefficient -0.006, 95% CI -0.008- -0.004, p<0.001) (high vs no SHS: 
p=0.010) and low exposure (adjusted coefficient -0.005, 95% CI -0.007- -0.003, p<0.001) (high 
vs low SHS: p=0.005) (Figure 1). After further adjustment for BMI category, telomere length 
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still decreased more rapidly among participants with high exposure to SHS (adjusted coefficient 
-0.017, 95% CI -0.030- -0.004, p=0.011) compared with no exposure group (adjusted 
coefficient -0.006, 95% CI -0.008- -0.004, p<0.001) (high vs no SHS: p=0.024) and with low 
exposure (adjusted coefficient -0.005, 95% CI -0.007- -0.003, p<0.001) (high vs low SHS: 
p=0.014).  
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Discussion 
 
Our findings suggest that high SHS exposure may accelerate normal biological ageing, as 
measured by leukocyte telomere length. Telomere attrition has been demonstrated to be 
associated with many age-related diseases including cardiovascular disease phenotypes, 7, 33, 34 
chronic obstructive pulmonary disease, 9 and certain types of cancer 10, 11. Therefore, it may be 
one of the mechanisms by which SHS is associated with these outcomes. 
 
Both active smoking and SHS exposure increase inflammation, thrombosis and oxidative stress. 
18, 35 Several studies have demonstrated an association between active smoking and telomere 
attrition. In a cross-sectional study of 1,122 healthy women aged 18-76 years, the investigators 
showed that never smokers had longer age-adjusted telomeres than former smokers, and both 
had longer telomeres than current smokers. Among current smokers, there was a dose 
relationship whereby each pack-year smoked equated to an additional 5 base pair (bp), or 18% 
of the average annual loss in age-adjusted telomere length. 8 In a cross-sectional study of 50 
life-long smokers and 26 never-smokers aged ≥55 years, cumulative active smoking exposure 
was found to be associated with relative telomere length, with a dose-response relationship 
whereby telomere length decreased with the increasing pack-years (r=-0.45, p<0.001). 9 In the 
Health Professionals Follow-up Study, researchers examined the association between telomere 
length and risk of bladder cancer among men aged 40-75 years in the USA. They conducted a 
case control study of 123 men with bladder cancer and 125 men without and demonstrated a 
similar dose-response relationship between relative telomere length and pack-years of active 
smoking among control smokers (r=-0.25, p=0.02). 10  
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Most of the research into the effect of passive exposure to tobacco has focused on prenatal 
exposure. A cross-sectional study examined the association between prenatal tobacco exposure 
and salivary relative telomere T/S ratio among 101 African American children aged 4-14 years. 
Among these children, 18.8% had prenatal tobacco exposure in their home, and 6.8% had 
mothers who smoked during pregnancy. Children who were exposed to smoke during 
pregnancy had shorter mean telomere length than those not exposed (mean±SD 6.4±1.5 vs. 
7.5±2.3; χ2 test p<0.05). 20 A prospective study, undertaken in Florida, examined the 
relationship between intrauterine tobacco exposure and fetal telomere length among 86 
pregnant women aged ≥ 18 years who were divided into non-smokers, passive smokers and 
active smokers. Fetal telomere length was determined using umbilical cord blood at birth and 
measured as T/S ratio. Smoking exposure was measured using both a questionnaire and a 
salivary cotinine test. They used simulation analysis to derive precise estimates and found a 
dose-response pattern, with shortest fetal telomere lengths among the offspring of active 
smokers followed by passive smokers and longest among non-smokers. 21  
 
In contrast, very few studies have been published to date on the association between SHS 
exposure in adulthood and telomere length. 26, 27 One cross-sectional study, conducted in the 
USA, examined 77 traffic officers exposed to high levels of traffic pollutants and 57 office 
workers as controls. Among the office workers, ever smokers had shorter telomeres than never 
smokers (geometric mean 1.17, 95% CI 1.10-1.25 for ever smokers vs 1.33, 95% CI 1.20-1.48 
for never smokers, p=0.04). The study reported no significant association between SHS 
exposure and telomere length. They also reported no significant association with either number 
of cigarettes smoked per day or pack-years. 26 The study was underpowered to study the effects 
of SHS exposure; of the 66 study participants who had never smoked, 28 reported exposure to 
SHS. In comparison, our study comprised 1,303 non-smokers of whom 524 reported SHS 
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exposure. This provided sufficient power to not only examine the overall effect of SHS 
exposure but also to explore whether there was evidence of a dose relationship across different 
levels of SHS exposure. Within the limits of comparing only three ordinal categories, our 
findings do not support a dose-relationship across the range of SHS. This is consistent with 
previous studies. A cohort study published in 2016, examined the association between smoking 
exposure, both active and secondhand, and telomere length among 6,456 adult participants in 
NHANES. 27 The investigators found no overall association between SHS and mean leukocyte 
telomere length when they treated the former as a continuous variable based on: self-reported 
time of exposure at home; self-reported time of exposure at work, and serum cotinine. Using 
quantile regression they found a significant inverse association between cotinine and leukocyte 
telomere length in the highest decile of telomere length only; confirming a non-linear 
relationship between SHS exposure and telomere length. 27 Another NHANES study provided 
similar findings based on disease end-points. Agarwal et al. reported no association between 
cotinine and peripheral arterial disease when cotinine was treated as a continuous variable. 36  
However, re-analysis using vingtiles demonstrated significantly increased risk of peripheral 
arterial disease among participants with the highest 15% of cotinine concentrations, suggestive 
of a threshold effect. 36 In order to maximise statistical power, we included ex-smokers with 
never smokers, as non-smokers, in this study but the majority of the ex-smokers had not smoked 
for more than a year.  
 
In the regression models, we were able to adjust for sex and deprivation quintile, and the 
association increased in magnitude. This suggests that individuals exposed to both 
socioeconomic deprivation and SHS exposure may be at particularly high risk of premature 
biological ageing. As with any non-randomised study, residual confounding is possible. For 
example, we were not able to adjust for physical activity data which were missing on a large 
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proportion of participants. However, a systematic review by Mundstock et al. concluded that 
there is currently insufficient good quality evidence to establish an association between physical 
activity and telomere length. 37  We did not have access to an objective measurement of SHS 
exposure, and therefore had to rely on self-report. Self-report is commonly used in large 
population studies because questionnaires are cheaper and easier to administer than biomarkers. 
Unlike biomarkers, questionnaires can be used to ascertain usual, or long-term, exposure and 
exposure in specific sites as well as overall exposure. 38 Cotinine, the primary metabolite of 
nicotine, is now the most commonly used biomarker of SHS. It can be measured in the saliva, 
blood or urine but only measures recent, overall exposure and concentrations vary, not only 
with nicotine exposure, but also individual nicotine metabolism, which changes with age and 
when pregnant. 39-42 Hair is the only tissue that can be used to measure long-term exposure but 
is rarely used. 43 Biomarkers are more accurate and not subject to potential bias 44; however, 
systematic errors are unlikely in this study since telomere length was unknown to participants 
and its measurement postdated self-report of SHS. Willemsen et al. demonstrated a moderate 
correlation (r=0.65, p<0.001) between self-reported average exposure to SHS at work and 
nicotine concentrations. 45  
 
Since the study was cross-sectional, temporal relationship cannot be established; however, 
reverse causation is unlikely to be plausible. Plausible mechanisms include cumulative 
oxidative stress-mediated damage and the stimulation of inflammation. Since the 
implementation of the comprehensive smoke-free legislation in Scotland in 2006,  exposure to 
SHS has declined in all public places covered by the legislation.46 This may be a possible 
explanation that in our study the number of participants who reported high exposure to SHS 
was small. The results of this study should be incorporated in future large-scale studies, ideally 
with access to objective measurements of SHS exposure, including repeat measures over time, 
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and sufficient statistical power to study never smokers in isolation to determine whether there 
is a dose-response relationship.  
 
 
Conclusion 
 
Our study adds to the relatively sparse literature on SHS exposure and biological ageing. Our 
findings suggest that high levels of SHS exposure may accelerate the shortening of telomeres 
that occurs naturally with age, and reinforces the importance of protecting the general public 
from exposure to SHS. 
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Table 1. General characteristics of the 1,303 non-smokers  
 
   
 Total hours per week to secondhand smoke  
 0 
(n=779) 
1-19 
(n=495) 
≥ 20 
(n=29) 
P value* 
     
     
Age group, n (%)     <0.001 
<45 years 368 (47.2) 327 (66.1) 20 (69.0)  
45-59 years 193 (24.8) 98 (19.8) 5 (17.2)  
≥60 years 218 (28.0) 70 (14.1) 4 (13.8)  
Missing  0 0 0  
Gender, n (%)    0.190 
Male 529 (67.9) 312 (63.0) 20 (69.0)  
Female 250 (32.1) 183 (27.0) 9 (31.0)  
Missing  0 0 0  
Deprivation, n (%)    <0.001 
1 (least deprived) 297 (38.1) 164 (33.1) 4 (13.8)  
2 211 (27.1) 123 (24.9) 6 (20.7)  
3 99 (12.7) 73 (14.8) 5 (17.2)  
4 52 (6.7) 64 (12.9) 8 (27.6)  
5 (most deprived) 50 (6.4) 44 (8.9) 4 (13.8)  
Missing  70 27 2  
BMI category    0.024 
<25 kg/m2 327 (42.0) 231 (46.7) 7 (24.1)  
25-30 kg/m2 312 (40.1) 170 (34.3) 12 (41.4)  
≥30 kg/m2 135 (17.3) 89 (18.0) 10 (34.5)  
Missing  5 5 0  
Smoking status, n (%)    <0.001 
Never smokers 496 (63.7) 336 (67.9) 14 (48.3)  
Ex-smokers stopped smoking > 1 year 272 (34.9) 122 (24.6) 10 (34.5)  
Ex-smokers stopped smoking ≤ 1 year 11 (1.4) 37 (7.5) 5 (17.2)  
Missing 0 0 0  
     
 
BMI body mass index; 
*chi-square tests 
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Figure 1. Change in telomere length T/S ratio per year of age and levels of secondhand 
smoke exposure among non-smokers (adjusted for sex and deprivation) 
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